Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BAYLOR COLLEGE OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1900-10-30

Employees: 10K

Market Cap: -

Website: http://www.bcm.edu

Clinical Trials

Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain

Not Applicable

Terminated

Conditions: Chronic Phantom Limb Pain

First Posted Date: 2007-01-22

Last Posted Date: 2022-08-12

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 15

Registration Number: NCT00425230

Locations: 🇺🇸
Micheal E. DeBakey Veterans Hospital, Houston, Texas, United States

Research Study for Major Depressive Disorder: Investigation of Glutamate Medications

Phase 4

Completed

Conditions: Major Depression

Interventions: Drug: Lamotrigine
Drug: Ketamine
Drug: Riluzole

First Posted Date: 2007-01-05

Last Posted Date: 2019-07-31

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 26

Registration Number: NCT00419003

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

Preventing Overweight in USAF Personnel: Minimal Contact Program

Not Applicable

Completed

Conditions: Obesity
Overweight

Interventions: Other: control group
Behavioral: Lifestyle Intervention

First Posted Date: 2007-01-01

Last Posted Date: 2016-06-24

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 500

Registration Number: NCT00417599

Locations: 🇺🇸
Wilford Hall Medical Center AFB, San Antonio, Texas, United States

Vector Delivery of the IL-12 Gene in Men With Prostate Cancer

Phase 1

Completed

Conditions: Prostatic Neoplasms
Prostate Cancer

First Posted Date: 2006-12-04

Last Posted Date: 2008-07-10

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 4

Registration Number: NCT00406939

Locations: 🇺🇸
Baylor College of Medicine Scott Department of Urology, Houston, Texas, United States

Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer

Phase 1

Completed

Conditions: Prostatic Neoplasms

First Posted Date: 2006-11-23

Last Posted Date: 2012-02-10

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 19

Registration Number: NCT00403221

Locations: 🇺🇸
Baylor College of Medicine - Scott Department of Urology, Houston, Texas, United States

Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department

Not Applicable

Withdrawn

Conditions: Asthma

First Posted Date: 2006-10-17

Last Posted Date: 2020-07-20

Lead Sponsor: Baylor College of Medicine

Registration Number: NCT00388739

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States

Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder

Phase 2

Completed

Conditions: PTSD

Interventions: Drug: NK1 Antagoist (GR205171)
Procedure: Psychophysiology (Trauma Script)
Procedure: Psychophysiology (Verbal Threat)
Procedure: Psychophysiology (Fear Conditioning)
Procedure: Psychophysiology (Affective Modulation)
Procedure: Psychophysiology (Heart rate variability)
Procedure: 24-hour plasma sampling
Procedure: Lumbar Puncture
Procedure: MRI

First Posted Date: 2006-10-04

Last Posted Date: 2019-07-31

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 47

Registration Number: NCT00383786

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
🇺🇸
Mt. Sinai Medical Center, New York, New York, United States

Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma

Phase 1

Terminated

Conditions: Hodgkins Lymphoma
Non-Hodgkin Lymphoma

First Posted Date: 2006-10-02

Last Posted Date: 2012-05-24

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 6

Registration Number: NCT00383097

Locations: 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸
The Methodist Hospital, Houston, Texas, United States

T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts

Phase 2

Completed

Conditions: Myelodysplastic Syndrome
X-linked Lymphoproliferative Disease (XLP)
Acute Myeloid Leukemia
Chronic Myelogenous Leukemia
Familial Hemophagocytic Lymphohistiocytosis (FLH)
Viral-associated Hemophagocytic Syndrome (VAHS)
Hemophagocytic Lymphohistiocytosis (HLH)
Acute Lymphoblastic Leukemia
Non Hodgkins Lymphoma

Interventions: Drug: Ara-C
Drug: Cyclophosphamide
Biological: Campath-1H
Radiation: Total Body Irradiation
Procedure: Stem Cell Infusion

First Posted Date: 2006-08-24

Last Posted Date: 2020-01-21

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 46

Registration Number: NCT00368355

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸
Texas Children's Hosptial, Houston, Texas, United States

Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)

Phase 1

Active, not recruiting

Conditions: Relapse
Lymphoma
Hodgkin's Disease
Lymphoma, Non-Hodgkin

Interventions: Biological: TGFbeta resistant LMP-specific CTLs

First Posted Date: 2006-08-24

Last Posted Date: 2024-11-07

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 8

Registration Number: NCT00368082

Locations: 🇺🇸
Houston Methodist Hospital, Houston, Texas, United States
🇺🇸
Texas Childrens Hospital, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy